Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of PHAARMASIA. For more details, see the PHAARMASIA quarterly results and PHAARMASIA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -5.0 |
No. of shares | m | 6.83 |
1 Week | % | 8.9 |
1 Month | % | 32.0 |
1 Year | % | 46.6 |
52 week H/L | Rs | 46.2/22.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
PHAARMASIA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 37 | 22 | 43 | 43 | 34 | |
Low | Rs | 14 | 10 | 13 | 24 | 20 | |
Sales per share (Unadj.) | Rs | 33.3 | 35.8 | 29.1 | 25.2 | 40.2 | |
Earnings per share (Unadj.) | Rs | 1.1 | 0.8 | 0.5 | -2.3 | -1.8 | |
Diluted earnings per share | Rs | 1.1 | 0.8 | 0.5 | -2.3 | -1.8 | |
Cash flow per share (Unadj.) | Rs | 1.8 | 1.4 | 1.0 | -1.8 | -1.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 18.8 | 19.6 | 20.0 | 17.7 | 15.8 | |
Adj. book value per share | Rs | 18.8 | 19.6 | 20.0 | 17.7 | 15.8 | |
Shares outstanding (eoy) | m | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | |
Price / Sales ratio | x | 0.8 | 0.5 | 1.0 | 1.3 | 0.7 | |
Avg P/E ratio | x | 22.8 | 20.5 | 61.2 | -14.6 | -14.8 | |
P/CF ratio (eoy) | x | 14.3 | 11.8 | 29.2 | -18.0 | -20.7 | |
Price / Book Value ratio | x | 1.4 | 0.8 | 1.4 | 1.9 | 1.7 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 177 | 110 | 191 | 226 | 186 | |
Total wages/salary | Rs m | 16 | 14 | 13 | 12 | 14 |
PHAARMASIA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 227 | 245 | 199 | 172 | 275 | |
Other income | Rs m | 6 | 6 | 9 | 5 | 5 | |
Total revenues | Rs m | 233 | 250 | 208 | 177 | 280 | |
Gross profit | Rs m | 7 | 8 | -1 | -17 | -15 | |
Depreciation | Rs m | 5 | 4 | 3 | 3 | 4 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | 8 | 10 | 5 | -16 | -14 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1 | 4 | 2 | 0 | -2 | |
Profit after tax | Rs m | 8 | 5 | 3 | -15 | -13 | |
Gross profit margin | % | 3.2 | 3.3 | -0.3 | -10.1 | -5.6 | |
Effective tax rate | % | 6.5 | 43.8 | 34.8 | 1.0 | 12.1 | |
Net profit margin | % | 3.4 | 2.2 | 1.6 | -9.0 | -4.6 |
PHAARMASIA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 192 | 199 | 86 | 83 | 150 | |
Current liabilities | Rs m | 198 | 194 | 79 | 89 | 173 | |
Net working cap to sales | % | -2.8 | 2.1 | 3.6 | -3.3 | -8.2 | |
Current ratio | x | 1.0 | 1.0 | 1.1 | 0.9 | 0.9 | |
Inventory Days | Days | 4 | 4 | 5 | 3 | 7 | |
Debtors Days | Days | 188,828,843 | 183,880,559 | 78,257,647 | 677 | 997 | |
Net fixed assets | Rs m | 141 | 137 | 133 | 129 | 133 | |
Share capital | Rs m | 68 | 68 | 68 | 68 | 68 | |
"Free" reserves | Rs m | 60 | 66 | 68 | 52 | 40 | |
Net worth | Rs m | 128 | 134 | 137 | 121 | 108 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 333 | 336 | 219 | 212 | 284 | |
Interest coverage | x | 23.5 | 27.0 | 40.8 | -389.5 | -30.8 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.7 | 0.7 | 0.9 | 0.8 | 1.0 | |
Return on assets | % | 2.4 | 1.7 | 1.5 | -7.3 | -4.3 | |
Return on equity | % | 6.1 | 4.0 | 2.3 | -12.8 | -11.6 | |
Return on capital | % | 6.8 | 7.4 | 3.6 | -12.9 | -12.8 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 3.7 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 8 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 3 | 0 | 0 | 0 | |
Fx outflow | Rs m | 8 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | -8 | 3 | 0 | 0 | 0 |
PHAARMASIA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1 | 1 | 3 | -2 | 7 | |
From Investments | Rs m | -1 | -0 | 0 | 0 | -0 | |
From Financial Activity | Rs m | 0 | -1 | -0 | 0 | -2 | |
Net Cashflow | Rs m | -0 | -0 | 2 | -2 | 5 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Maneesh R Sapte | COMP SEC: Urvashi Bhatia | YEAR OF INC: 1981 | BSE CODE: 523620 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare PHAARMASIA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.